Cargando…
Surveillance strategies for precancerous gastric conditions after Helicobacter pylori eradication: There is still need for a tailored approach
Prevailing evidence declares that Helicobacter pylori (H. pylori) eradication therapy could shift precancerous gastric conditions (PGC) and positively confines gastric cancer (GC) risk during long-term endoscopic follow-up. Nonetheless, there is a yet unsolved controversy regarding the best-individu...
Autores principales: | Shahini, Endrit, Maida, Marcello |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Baishideng Publishing Group Inc
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8678819/ https://www.ncbi.nlm.nih.gov/pubmed/35046629 http://dx.doi.org/10.3748/wjg.v27.i46.8033 |
Ejemplares similares
-
Helicobacter pylori Eradication Reduces the Metachronous Recurrence of Gastric Neoplasms by Attenuating the Precancerous Process
por: Jung, Da Hyun, et al.
Publicado: (2015) -
Helicobacter pylori eradication may influence timing of endoscopic surveillance for gastric cancer in patients with gastric precancerous lesions: A retrospective study
por: Dore, Maria Pina, et al.
Publicado: (2018) -
Helicobacter Pylori Eradication Therapy: Still a Challenge
por: Hafeez, Muhammad, et al.
Publicado: (2021) -
The need for a patient-tailored Helicobacter pylori eradication protocol prior to bariatric surgery
por: Pintar, Tadeja, et al.
Publicado: (2018) -
Tailored eradication strategy vs concomitant therapy for Helicobacter pylori eradication treatment in Korean patients
por: Choi, Youn I, et al.
Publicado: (2021)